Prenetics Global LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Prenetics Global Limited has filed an amendment to its 2025 annual report on Form 20-F, primarily to revise disclosures related to its holding company structure, cash transfers, enforceability of civil liabilities, operating metrics, and financial measures.
NASDAQ
Insighta Holdings Limited's FY2025 financial statements reveal a significant increase in profit before tax, driven by substantial other income, despite a decrease in revenue from laboratory testing kits.
NASDAQ
Prenetics Global Limited filed an amendment to its 2024 annual report to incorporate the separate financial statements of its significant equity method investment, Insighta Holdings Limited, as mandated by SEC regulations.
NASDAQ
20-F: Prenetics Global Limited Files 20-F Annual Report, Highlights Strategic Shift to Consumer Health
Prenetics Global Limited's 20-F filing details its financial performance and strategic pivot towards consumer health brands like IM8, Europa, and CircleDNA.
NASDAQ
Prenetics Global Limited's 20-F filing provides a comprehensive overview of the company's financial performance, operational risks, and strategic direction for the fiscal year ended December 31, 2023.